SlideShare a Scribd company logo
ENZYME
Sub: BIOCHEMISTRY AND CLINICAL PATHOLOGY
D. PHARM. Ist Year
Presented by
Dr. ARUN KUMAR
M. Pharm., PDCTM, PhD
Principal
PARMARTH COLLEGE OF PHARMACY, HAPUR
Introduction
• Enzymes are biological catalysts synthesized
by living cells that accelerate biochemical
reactions.
• The orderly course of metabolic processes is
only possible because each cell is equipped with
its own genetically determined set of enzymes
• It is only this that allows coordinated sequences
of reactions - metabolic pathways
• Involved in many regulatory mechanisms.
• Almost all enzymes are proteins except
catalytically active ribonucleic acids, the
ribozymes
Enzyme
• Enzymes are characterized by three
distinctive features:
• Catalytic Power
– Ability to catalyses biochemical reaction
• Specificity
– A given enzyme is very selective
– Both in the substances with which it interacts
and in the reaction that it catalyzes
• Regulation
– Metabolic inhibitors and activators
Enzyme Nomenclature
• Traditionally, enzymes often were named by
adding the suffix –ase to the substrate upon
which they acted
• Ex: phosphatase, urease, catalase, proteases
• Confusion arose from these trivial naming.
• So a new system of nomenclature of enzyme was
developed based on nature of reaction it helps
• Six classes of reactions are recognized
– Within each class are subclasses, and under each
subclass are subsubclasses within which individual
enzymes are listed
Classification of Enzyme
• Enzyme are classified on the basis of action it performs
– Oxidoreductases - oxidation–reduction reactions
• Phosphate dehydrogenase
– Transferases - transfer of functional groups
• Methyltransferases, Carboxyltransferases
– Hydrolases - hydrolysis reactions
• Carboxylic ester hydrolases
– Isomerases - isomerization reactions
• Epimerases
– Lyases - addition to double bonds
• Carboxy lyases, Aldehyde lyases
– Ligases - formation of bonds with ATP cleavage
• Amino acid–RNA ligases
Intracellular and extracellular enzymes
o Intracellular
o enzymes are synthesized and retained in the cell for the
use of cell itself.
o They are found in the cytoplasm, nucleus, mitochondria
and chloroplast.
Example: Oxydoreductase catalyses biological
oxidation, Enzymes involved in reduction in the
mitochondria.
o Extracellular
o enzymes are synthesized in the cell but secreted from the
cell to work externally.
Example : Digestive enzyme produced by the
pancreas, are not used by the cells in the pancreas but are
transported to the
duodenum
Chemical Properties
• Most of enzymes carry out their functions relying
solely on their protein structure
• Many others require non-protein components –
cofactors
– Usually metal ion or non-protein organic part
(Coenzyme)
• Less complex than proteins, tend to be stable to
heat
• Many coenzymes are vitamins or contain vitamins
as part of their structure
• Functional unit of enzyme is known as holoenzyme
– Holenzyme = Apoenzyme + Coenzyme
• Apoenzyme : protein without any catalytic activity
• If the enzyme is made of single polypeptide –
monomeric enzyme. Ex: ribonuclease, trypsin
• If the enzyme is made up of more than one
polypeptide – oligomeric enzyme. Ex: lactate
dehydrogenase, aspartate transcarbamoylase
• Multienzyme complex: have multiple enzyme
unit to carry out different reaction in sequence
Factors effecting enzyme activity
• The contact between enzyme and substrate is the
most essential pre-requisite for enzyme activity.
• The important factors that influence the enzyme
reaction are
– Concentration of Substrate
– Concentration of Enzyme
– Temperature
– pH
– Product concentration
– Activators
– Time
– Light and radiation
Concentration of Substrate:
• The frequency with which molecules
collide is directly proportionate to their
concentrations
Rate ∝ [A]n[B]m, Rate= k[A]n[B]m
– where, nA + mB →P;k =rate constant
• The sum of the molar ratios of the reactants defines
the kinetic order of the reaction
• In the example above, reaction is said to be of (n+m)
order overall but n order with respect to A and m
order with respect to B
Michaelis-Menten Constant Km
• Also known as Haldane’s Constant
• Substrate concentration to produce half
maximum velocityin an enzyme catalyst
reaction
• Km is constant and a chracterstic feature of a
given enzyme – strength of Enzyme Substrate
(ES) complex
• Low Km value indicates a strong affinity between
enzyme and substrate
• Majority of Enzyme Km value – 10-5 to 10-2
Michaelis-Menten Constant Km
Michaelis-Menten
Reaction
Concentration of Enzyme
• Reaction velocity is directly proportional to
concentration of enzyme
• Serum enzyme for diagnosis of disease
– Known volume of serum and substrate taken at
optimum pH and temperature
– Enzyme is assayed in laboratory
Temperature
• Velocity of an enzyme reaction increase with the
increase in temperature up to a maximum and then
declines
• Increase in temperature causes increases the
kinetic energy of molecules
• A bell-shaped curve is usually observed
• Temperature coefficient Q10 : increase in enzyme
velocity when the temperature is increased by 100C
• Optimum temperature for most of enzyme – 40 – 45
0C
• Beyond 500C there is denaturation of enzyme
pH
• Most intracellular enzymes exhibit optimal activity at
pH values between 6 - 8.
• Balance between enzyme denaturation at high or low
pH and effects on the charged state of the enzyme,
the substrates, or both
• Exception – pepsin (1-2), acid phosphatase (4-
5), alkaline phophatase (10-11)
Activators
• Certain metallica cations – Mn, Mg, Zn, Ca, Co,
Cu, Na, K.
• It acts in a various ways
– Combining with substrate
– Formation of E-S metal complex, direct participation
in the reaction and bringing a conformational
changes in enzyme
• There are 2 categories of enzyme requiring
metals for their activity
• Metal activated enzyme:Not tightly held by the enzyme and can
be exchanged easily. Ex: ATPAase (Mg and Ca) and Enolase
• Metalloenzyme: Hold the metal tightly. Ex: alcohol
dehydrogenase, carbonic anhydrase, alkaline phosphatase,
carboxypeptidase
Other Factor
• Product concentration: Accumulation of
reaction products generally decreases the
enzyme velocity
• Light and radiation: exposure to UV, beta-
gamma and X-rays inactivates certain
enzyme
– Formation of peroxides, ex: UV rays inhibit salivary
amylase activity
Mechanism of Enzyme Action:
Active Sites
• The active site of an enzyme is the region that binds
substrates, co-factors and prosthetic groups and
contains residue that helps to hold the substrate.
• Active sites generally occupy less than 5% of the total
surface area of enzyme.
• Active site has a specificshapedue to tertiary
structure of protein.
• A change in the shape of protein affects the
shape of active site and function of the enzyme.
Active Sites
This model (above) is an enzyme called
Ribonuclease S, that breaks up RNA molecules. It
has three active sites(arrowed).
Active site:
The active site contains both binding and
catalytic regions. The substrate is drawn to
the enzyme’s surfaceand the substrate
molecule(s) are positioned in a way to
promote a reaction: either joining two
molecules together or splitting up a larger
one.Enzyme molecule:
The complexity of the active
site is what makes each
enzyme so specific (i.e.
precise in terms ofthe
substrate it acts on).
Substrate molecule: Substrate
molecules are the chemicals that an
enzyme acts on. They are drawn
into the cleft of the enzyme.
Mechanism of enzyme action
• The catalytic efficiency of enzymes is explained by two
perspectives:
Thermodynamic
changes
Processes at the
active site
Thermodynamic changes
• All chemical reactions have energy barriers between
reactants and products.
• The difference in transitional state and substrate is called
activational barrier.
Lock and Key Model
Substrate
Enzyme
Products
Symbolic representation of the lock and key model of enzyme action.
1. A substrate is drawn into the active sites of theenzyme.
2. The substrate shape must be compatible with the enzymes active site in order to fit and
be reacted upon.
3. The enzyme modifies the substrate. In this instance the substrateis broken down,
releasing two products.
I n d u c e d f i t m o d e l
• More recent studies have revealed that the process is much
more likely to involve an induced fit model(proposed by
DANIAL KOSH LAND in 1958).
• According to this exposure of an enzyme to substrate cause a
change in enzyme, which causes the active site to change it’s
shape to allow enzyme and substrate to bind.
In h i b i t i o n
o The prevention of an enzyme processas a result of interaction of
inhibitors with the enzyme.
 INHIBITORS:
Any substance that can diminish the velocity of an enzyme
catalyzed reaction is called an inhibitor.
A. REVERSIBLE INHIBITION
o It is an inhibition of enzyme activity in which the
inhibiting molecular entity can associate and dissociate
from the protein‘s bindingsite.
TYPES OF REVERSIBLE INHIBITION
o There are four types:
 Competitive inhibition.
 Uncompetitive inhibition.
 Mixed inhibition.
 Non-competitive inhibition.
C o m p e t i t i v e i n h i b i t i o n
• In this type of inhibition, the inhibitors compete with
the substrate for the active site. Formation of E.S
complex is reduced while a new E.I complex is
formed.
Example:
• Statin drugs such as lipitor compete with HMG-
CoA(substrate) and inhibit the active site of HMG
CoA-REDUCTASE (that bring about the catalysis of
cholesterol synthesis).
U n c o m p e t i t i v e I n h i b i t i o n
• In this type of inhibition, inhibitor does not compete with the
substrate for the active site of enzyme instead it binds to
another site known as allosteric site.
Example:
• Drugs to treat cases of poisoning by methanol or ethylene
glycol act as uncompetitive inhibitors.
• Tetramethylene sulfoxide and 3- butylthiolene 1-oxide are
uncompetitive inhibitors of liver alcohaldehydrogenase.
MI X E D INHIBITION
o In this type of inhibition both E.I and E.S.I
complexes are formed.
o Both complexes are catalytically inactive.
N o n c o m p e t i t i v e
i n h i b i t i o n
o It is a special case of inhibition.
o In this inhibitor has the same affinity for either
enzyme E or the E.S complex.
B. Irreversible i n h i b i t i o n
• This type of inhibition involves the covalent attachment of the
inhibitor to the enzyme.
• The catalytic activity of enzyme is completely lost.
• It can only be restored only by synthesizing molecules.
www.facebook.com/notesdent
al
E x a m p l e s o f i r r e v e r s i b l e i n h i b i t i o n
• Aspirin which targets and covalently modifies a
key enzyme involved in inflammation is an
irreversible inhibitor.
• SUICIDE INHIBITION :
It is an unusual type of irreversible inhibition
where the enzyme converts the inhibitor into a
reactive form in its active site.
Diagnostic Importance of Enzyme
• Estimation of enzyme activities in biological
fluid is of great clinical importance.
• The enzyme can be divided in 2 groups:
– Plasma Specific or plasma functional enzyme
– Non-plasma specific or plasma non-functional
enzyme
Plasma Specific
• Present in the plasma normally and have specific
fucntion
• Their value is higher in plasma than tissue
• They are mainly synthesized in liver and enter the
circulation
• Ex: Lipoprotein lipase, plasmin, thrombin, choline
esterase, ceruloplasmin
• Impairment of liver function or genetic disorder –
leads to enzyme deficiency
• Wilson disease – deficiency of ceruloplasmin
Non-plasma specific
• These enzymes are present in the low level
in plasma compared to the tissue
• Estimation of activities of these enzymes serves for
the diagnosis and prognosis of several disease -
markers of disease
• The raised enzyme level may indicate
– Cellular damage
– Increased rate of cell turnover
– Proliferation of cells
– Increased synthesis of enzymes
Important Diagnostic Enzymes
• Amylase – Acute pancreatitis
• Serum glutamate pyruvate transferase (SGPT) – liver
disease (hepatitis)
• Serum glutamate oxaloacetate transaminase (SGOT) –
Heart attacks (myocardial infarction)
• Alkaline phosphatase – Rickets, obstructive jaundice
• Acid phophatase – cancer of prostate gland
• Lactate dehydrogenase (LDH) – heart attacks, liver disease
• Creatinine phosphokinase (CPK) – myocardial infarction
• Aldolase – Muscular dystrophy
Amylase
• Activity increased in acute pancreatitis
• Normal level – 0.2-1.5 IU/l
• Peak value in 8-12 hrs – onset of disease and
returns to normal in 3-4 days
• Urine analysis
• Serum analysis – chronic pancreatitis, acute
parotitis (mumps) and obstruction of
pancreatic duct
Serum glutamate pyruvate transferase
(SGPT)
• Also known as Alanine transaminase (ALT)
• Normal level – 3-4.0 IU/l
• Acute hepatitis of viralor toxic origin
• Jaundice and cirrohosis of liver
Serum glutamate oxaloacetate
transaminase (SGOT)
• Also known as Aspartate transaminase
• Normal 4-4.5 IU/l
• Increase in myocardial infarction and also in
liver diseases
• SGPT is more specific for liver disease and
SGOT for MI – SGPT more cytosomal enzyme
while SGOT is cytosol and mitochondria
Alkaline phosphatase
• Elevated in bone and liver disease
• Normal : 25-90 IU/l
• Diagnosis for
– Rickets,
– Hyperparathyroidism,
– Carcinoma of bone
– Obstructive jaundice
– Paget’s Disease
Acid phophatase
• Normal : 0.5 -4 KA units/dl
• Increased in cancer of prostate gland and
Paget’s Disease
• Good tumor marker
Creatinine phosphokinase (CPK)
• Normal : 10-50 IU/l
• Diagnosis of
– MI - Very early detection
– Muscular dystrophy
– Hypothyroidism
– Alcoholism
Lactate dehydrogenase (LDH)
• At least five different isozymes
• Assess the timing and extent of heart damage
due to myocardial infarction MI (heart attack)
– 12 hrs of MI: blood level of total LDH increases, and
there is more LDH2 than LDH1
– 24 hrs of MI: more LDH1 than LDH2
Type Composition Location
LDH1 HHHH Heart and erythrocyte
LDH2 HHHM Heart and erythrocyte
LDH3 HHMM Brain and kidney
LDH4 HMMM Skeletal muscle and liver
LDH5 MMMM Skeletal muscle and liver
Aldolase
• Normal ; 2+6 IU/l
• Diagnosis of
– Muscular dystrophy
– Liver disease
– Myocardial infarction
– Myasthenia gravis
– Leukemia

More Related Content

What's hot

Important questions of Human anatomy and physiology 2
Important questions of Human anatomy and physiology 2 Important questions of Human anatomy and physiology 2
Important questions of Human anatomy and physiology 2
Payaamvohra1
 
nucleic acid unit-5 biochemistry and clinical pathology, D.Pharm 2nd year- .pptx
nucleic acid unit-5 biochemistry and clinical pathology, D.Pharm 2nd year- .pptxnucleic acid unit-5 biochemistry and clinical pathology, D.Pharm 2nd year- .pptx
nucleic acid unit-5 biochemistry and clinical pathology, D.Pharm 2nd year- .pptx
Aanchal Gupta
 
Indian pharmacopoeia
Indian pharmacopoeiaIndian pharmacopoeia
Indian pharmacopoeia
SRMUBarabanki
 
History of Pharmacy
History of PharmacyHistory of Pharmacy
History of Pharmacy
Dr K SUDHEER KUMAR KANDIBANDA
 
Pharmaceutical education in india
Pharmaceutical education in indiaPharmaceutical education in india
Pharmaceutical education in india
Naresh Gorantla
 
PROTEINS unit3 biochemistry and clinical pathology, D.Pharm 2nd year.pptx
PROTEINS unit3  biochemistry and clinical pathology, D.Pharm 2nd year.pptxPROTEINS unit3  biochemistry and clinical pathology, D.Pharm 2nd year.pptx
PROTEINS unit3 biochemistry and clinical pathology, D.Pharm 2nd year.pptx
Aanchal Gupta
 
History of pharmacy
History of pharmacyHistory of pharmacy
History of pharmacy
sunidhi mahant
 
Pharmacy practice regulations, 2015
Pharmacy practice regulations, 2015Pharmacy practice regulations, 2015
Pharmacy practice regulations, 2015
Pharmacy
 
Posology
PosologyPosology
Posology
Ravikumar Patil
 
Biochemistry Biochemistry and clinical pathology -NOTES
Biochemistry Biochemistry and clinical pathology -NOTESBiochemistry Biochemistry and clinical pathology -NOTES
Biochemistry Biochemistry and clinical pathology -NOTES
twilight89
 
History of pharmacy and pharmacopoeia
History of pharmacy and pharmacopoeiaHistory of pharmacy and pharmacopoeia
History of pharmacy and pharmacopoeia
jagan vana
 
Labels Sample. Part 1
Labels Sample. Part 1Labels Sample. Part 1
Labels Sample. Part 1
Javeria Fateh
 
Test for identification of type of emulsion
Test for identification of type of emulsionTest for identification of type of emulsion
Test for identification of type of emulsion
SantuMistree4
 
Good Regulatory Practice.pptx
Good Regulatory Practice.pptxGood Regulatory Practice.pptx
Good Regulatory Practice.pptx
Satyaji College of Pharmacy, Mehkar
 
Scope of pharmacy ppt
Scope of pharmacy pptScope of pharmacy ppt
Scope of pharmacy ppt
Deepak Sarangi
 
Compounding in hospital.pptx
Compounding in hospital.pptxCompounding in hospital.pptx
Compounding in hospital.pptx
Archana Chavhan
 
Introduction to Pharmaceutical analysis - I (HRB)
  Introduction to Pharmaceutical analysis - I (HRB)  Introduction to Pharmaceutical analysis - I (HRB)
Introduction to Pharmaceutical analysis - I (HRB)
Harshadaa bafna
 
State pharmacy council and joint state pharmacy council
State pharmacy council and joint state pharmacy councilState pharmacy council and joint state pharmacy council
State pharmacy council and joint state pharmacy council
Devsthali Vidyapeeth College of Pharmacy
 
Prescription
Prescription Prescription
Prescription
Ravikumar Patil
 
Indian pharmacopoeia from initial to latest edition
Indian pharmacopoeia  from initial to latest editionIndian pharmacopoeia  from initial to latest edition
Indian pharmacopoeia from initial to latest edition
Associate Professor, B.Pharmacy College, Rampura, Godhra, Gujarat, India
 

What's hot (20)

Important questions of Human anatomy and physiology 2
Important questions of Human anatomy and physiology 2 Important questions of Human anatomy and physiology 2
Important questions of Human anatomy and physiology 2
 
nucleic acid unit-5 biochemistry and clinical pathology, D.Pharm 2nd year- .pptx
nucleic acid unit-5 biochemistry and clinical pathology, D.Pharm 2nd year- .pptxnucleic acid unit-5 biochemistry and clinical pathology, D.Pharm 2nd year- .pptx
nucleic acid unit-5 biochemistry and clinical pathology, D.Pharm 2nd year- .pptx
 
Indian pharmacopoeia
Indian pharmacopoeiaIndian pharmacopoeia
Indian pharmacopoeia
 
History of Pharmacy
History of PharmacyHistory of Pharmacy
History of Pharmacy
 
Pharmaceutical education in india
Pharmaceutical education in indiaPharmaceutical education in india
Pharmaceutical education in india
 
PROTEINS unit3 biochemistry and clinical pathology, D.Pharm 2nd year.pptx
PROTEINS unit3  biochemistry and clinical pathology, D.Pharm 2nd year.pptxPROTEINS unit3  biochemistry and clinical pathology, D.Pharm 2nd year.pptx
PROTEINS unit3 biochemistry and clinical pathology, D.Pharm 2nd year.pptx
 
History of pharmacy
History of pharmacyHistory of pharmacy
History of pharmacy
 
Pharmacy practice regulations, 2015
Pharmacy practice regulations, 2015Pharmacy practice regulations, 2015
Pharmacy practice regulations, 2015
 
Posology
PosologyPosology
Posology
 
Biochemistry Biochemistry and clinical pathology -NOTES
Biochemistry Biochemistry and clinical pathology -NOTESBiochemistry Biochemistry and clinical pathology -NOTES
Biochemistry Biochemistry and clinical pathology -NOTES
 
History of pharmacy and pharmacopoeia
History of pharmacy and pharmacopoeiaHistory of pharmacy and pharmacopoeia
History of pharmacy and pharmacopoeia
 
Labels Sample. Part 1
Labels Sample. Part 1Labels Sample. Part 1
Labels Sample. Part 1
 
Test for identification of type of emulsion
Test for identification of type of emulsionTest for identification of type of emulsion
Test for identification of type of emulsion
 
Good Regulatory Practice.pptx
Good Regulatory Practice.pptxGood Regulatory Practice.pptx
Good Regulatory Practice.pptx
 
Scope of pharmacy ppt
Scope of pharmacy pptScope of pharmacy ppt
Scope of pharmacy ppt
 
Compounding in hospital.pptx
Compounding in hospital.pptxCompounding in hospital.pptx
Compounding in hospital.pptx
 
Introduction to Pharmaceutical analysis - I (HRB)
  Introduction to Pharmaceutical analysis - I (HRB)  Introduction to Pharmaceutical analysis - I (HRB)
Introduction to Pharmaceutical analysis - I (HRB)
 
State pharmacy council and joint state pharmacy council
State pharmacy council and joint state pharmacy councilState pharmacy council and joint state pharmacy council
State pharmacy council and joint state pharmacy council
 
Prescription
Prescription Prescription
Prescription
 
Indian pharmacopoeia from initial to latest edition
Indian pharmacopoeia  from initial to latest editionIndian pharmacopoeia  from initial to latest edition
Indian pharmacopoeia from initial to latest edition
 

Similar to D. Pharm BIOCHEMISTRY AND CLINICAL PATHOLOGY Enzyme

Enzyme structure and Mechanism of Action
Enzyme structure and Mechanism of Action Enzyme structure and Mechanism of Action
Enzyme structure and Mechanism of Action
Swati Raysing
 
Biochemistry lecture notes enzymes
Biochemistry lecture notes enzymesBiochemistry lecture notes enzymes
Biochemistry lecture notes enzymes
Rengesh Balakrishnan
 
ENZYMES.pptx
ENZYMES.pptxENZYMES.pptx
ENZYMES.pptx
Perfect40
 
CHAPTER 6.pptx
CHAPTER 6.pptxCHAPTER 6.pptx
CHAPTER 6.pptx
Sayali Powar
 
ENZYMES.pptx
ENZYMES.pptxENZYMES.pptx
ENZYMES.pptx
Jayati Shrivastava
 
ENZYME BIOCHEMISTRY
ENZYME BIOCHEMISTRYENZYME BIOCHEMISTRY
ENZYME BIOCHEMISTRY
Naresh Panigrahi
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
Sayali Powar
 
Enzymes
EnzymesEnzymes
Enzymes
ShaliniBarad
 
Enzymes.pptx
Enzymes.pptxEnzymes.pptx
Enzymes.pptx
ABHIJIT BHOYAR
 
Enzymology CHS VET-1 bsa.pdf
Enzymology CHS VET-1 bsa.pdfEnzymology CHS VET-1 bsa.pdf
Enzymology CHS VET-1 bsa.pdf
BenedictLongok
 
Enzymes
EnzymesEnzymes
Enzymes
ASHIKH SEETHY
 
Enzyme and Coenzyme
Enzyme and CoenzymeEnzyme and Coenzyme
Enzyme and Coenzyme
PotatoFries12
 
Enzymes kinetics
Enzymes kinetics Enzymes kinetics
Enzymes kinetics
SujataRao11
 
Enzymes-.pdf
Enzymes-.pdfEnzymes-.pdf
Enzymes-.pdf
AlodiaPastorizo
 
Enzymes.pptx
Enzymes.pptxEnzymes.pptx
Enzymes.pptx
AlyssaMaeAzarcon
 
Overview of enzyme
Overview of enzymeOverview of enzyme
Enzyme
EnzymeEnzyme

Similar to D. Pharm BIOCHEMISTRY AND CLINICAL PATHOLOGY Enzyme (20)

Enzyme structure and Mechanism of Action
Enzyme structure and Mechanism of Action Enzyme structure and Mechanism of Action
Enzyme structure and Mechanism of Action
 
Biochemistry lecture notes enzymes
Biochemistry lecture notes enzymesBiochemistry lecture notes enzymes
Biochemistry lecture notes enzymes
 
ENZYMES.pptx
ENZYMES.pptxENZYMES.pptx
ENZYMES.pptx
 
CHAPTER 6.pptx
CHAPTER 6.pptxCHAPTER 6.pptx
CHAPTER 6.pptx
 
ENZYMES.pptx
ENZYMES.pptxENZYMES.pptx
ENZYMES.pptx
 
ENZYME BIOCHEMISTRY
ENZYME BIOCHEMISTRYENZYME BIOCHEMISTRY
ENZYME BIOCHEMISTRY
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
51196538 enzymes chapter 3
51196538 enzymes chapter 351196538 enzymes chapter 3
51196538 enzymes chapter 3
 
Enzymes
EnzymesEnzymes
Enzymes
 
Enzymes.pptx
Enzymes.pptxEnzymes.pptx
Enzymes.pptx
 
Enzymology CHS VET-1 bsa.pdf
Enzymology CHS VET-1 bsa.pdfEnzymology CHS VET-1 bsa.pdf
Enzymology CHS VET-1 bsa.pdf
 
Enzymes
EnzymesEnzymes
Enzymes
 
Module 5.pptx
Module 5.pptxModule 5.pptx
Module 5.pptx
 
Enzyme and Coenzyme
Enzyme and CoenzymeEnzyme and Coenzyme
Enzyme and Coenzyme
 
Enzymes kinetics
Enzymes kinetics Enzymes kinetics
Enzymes kinetics
 
Enzymes-.pdf
Enzymes-.pdfEnzymes-.pdf
Enzymes-.pdf
 
Enzymes.pptx
Enzymes.pptxEnzymes.pptx
Enzymes.pptx
 
Overview of enzyme
Overview of enzymeOverview of enzyme
Overview of enzyme
 
Enzymes.ppt
Enzymes.pptEnzymes.ppt
Enzymes.ppt
 
Enzyme
EnzymeEnzyme
Enzyme
 

More from Arun Kumar

Rain water harvesting by Dr. Arun Kumar
Rain water harvesting by Dr. Arun KumarRain water harvesting by Dr. Arun Kumar
Rain water harvesting by Dr. Arun Kumar
Arun Kumar
 
Hepatitis, alcohol liver disease
Hepatitis, alcohol liver diseaseHepatitis, alcohol liver disease
Hepatitis, alcohol liver disease
Arun Kumar
 
Cancer
CancerCancer
Cancer
Arun Kumar
 
PATHOLOGY OF BLOOD AND URINE
PATHOLOGY OF BLOOD AND URINEPATHOLOGY OF BLOOD AND URINE
PATHOLOGY OF BLOOD AND URINE
Arun Kumar
 
Thyroid diseases BY DR ARUN KUMAR
Thyroid diseases BY DR ARUN KUMARThyroid diseases BY DR ARUN KUMAR
Thyroid diseases BY DR ARUN KUMAR
Arun Kumar
 
Epilepsy Presented by Dr. Arun Kumar
Epilepsy Presented by Dr. Arun KumarEpilepsy Presented by Dr. Arun Kumar
Epilepsy Presented by Dr. Arun Kumar
Arun Kumar
 
Asthma Presentation by Dr. Arun Kumar
Asthma Presentation by Dr. Arun KumarAsthma Presentation by Dr. Arun Kumar
Asthma Presentation by Dr. Arun Kumar
Arun Kumar
 
HYPERTENSION TOPIC PREPARED BY DR. ARUN KUMAR
HYPERTENSION TOPIC PREPARED BY DR. ARUN KUMARHYPERTENSION TOPIC PREPARED BY DR. ARUN KUMAR
HYPERTENSION TOPIC PREPARED BY DR. ARUN KUMAR
Arun Kumar
 

More from Arun Kumar (8)

Rain water harvesting by Dr. Arun Kumar
Rain water harvesting by Dr. Arun KumarRain water harvesting by Dr. Arun Kumar
Rain water harvesting by Dr. Arun Kumar
 
Hepatitis, alcohol liver disease
Hepatitis, alcohol liver diseaseHepatitis, alcohol liver disease
Hepatitis, alcohol liver disease
 
Cancer
CancerCancer
Cancer
 
PATHOLOGY OF BLOOD AND URINE
PATHOLOGY OF BLOOD AND URINEPATHOLOGY OF BLOOD AND URINE
PATHOLOGY OF BLOOD AND URINE
 
Thyroid diseases BY DR ARUN KUMAR
Thyroid diseases BY DR ARUN KUMARThyroid diseases BY DR ARUN KUMAR
Thyroid diseases BY DR ARUN KUMAR
 
Epilepsy Presented by Dr. Arun Kumar
Epilepsy Presented by Dr. Arun KumarEpilepsy Presented by Dr. Arun Kumar
Epilepsy Presented by Dr. Arun Kumar
 
Asthma Presentation by Dr. Arun Kumar
Asthma Presentation by Dr. Arun KumarAsthma Presentation by Dr. Arun Kumar
Asthma Presentation by Dr. Arun Kumar
 
HYPERTENSION TOPIC PREPARED BY DR. ARUN KUMAR
HYPERTENSION TOPIC PREPARED BY DR. ARUN KUMARHYPERTENSION TOPIC PREPARED BY DR. ARUN KUMAR
HYPERTENSION TOPIC PREPARED BY DR. ARUN KUMAR
 

Recently uploaded

How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
Celine George
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
Nguyen Thanh Tu Collection
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
GeoBlogs
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
AzmatAli747758
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
Vivekanand Anglo Vedic Academy
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
PedroFerreira53928
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
bennyroshan06
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
PedroFerreira53928
 

Recently uploaded (20)

How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
 

D. Pharm BIOCHEMISTRY AND CLINICAL PATHOLOGY Enzyme

  • 1. ENZYME Sub: BIOCHEMISTRY AND CLINICAL PATHOLOGY D. PHARM. Ist Year Presented by Dr. ARUN KUMAR M. Pharm., PDCTM, PhD Principal PARMARTH COLLEGE OF PHARMACY, HAPUR
  • 2. Introduction • Enzymes are biological catalysts synthesized by living cells that accelerate biochemical reactions. • The orderly course of metabolic processes is only possible because each cell is equipped with its own genetically determined set of enzymes • It is only this that allows coordinated sequences of reactions - metabolic pathways • Involved in many regulatory mechanisms. • Almost all enzymes are proteins except catalytically active ribonucleic acids, the ribozymes
  • 3. Enzyme • Enzymes are characterized by three distinctive features: • Catalytic Power – Ability to catalyses biochemical reaction • Specificity – A given enzyme is very selective – Both in the substances with which it interacts and in the reaction that it catalyzes • Regulation – Metabolic inhibitors and activators
  • 4. Enzyme Nomenclature • Traditionally, enzymes often were named by adding the suffix –ase to the substrate upon which they acted • Ex: phosphatase, urease, catalase, proteases • Confusion arose from these trivial naming. • So a new system of nomenclature of enzyme was developed based on nature of reaction it helps • Six classes of reactions are recognized – Within each class are subclasses, and under each subclass are subsubclasses within which individual enzymes are listed
  • 5. Classification of Enzyme • Enzyme are classified on the basis of action it performs – Oxidoreductases - oxidation–reduction reactions • Phosphate dehydrogenase – Transferases - transfer of functional groups • Methyltransferases, Carboxyltransferases – Hydrolases - hydrolysis reactions • Carboxylic ester hydrolases – Isomerases - isomerization reactions • Epimerases – Lyases - addition to double bonds • Carboxy lyases, Aldehyde lyases – Ligases - formation of bonds with ATP cleavage • Amino acid–RNA ligases
  • 6. Intracellular and extracellular enzymes o Intracellular o enzymes are synthesized and retained in the cell for the use of cell itself. o They are found in the cytoplasm, nucleus, mitochondria and chloroplast. Example: Oxydoreductase catalyses biological oxidation, Enzymes involved in reduction in the mitochondria. o Extracellular o enzymes are synthesized in the cell but secreted from the cell to work externally. Example : Digestive enzyme produced by the pancreas, are not used by the cells in the pancreas but are transported to the duodenum
  • 7. Chemical Properties • Most of enzymes carry out their functions relying solely on their protein structure • Many others require non-protein components – cofactors – Usually metal ion or non-protein organic part (Coenzyme) • Less complex than proteins, tend to be stable to heat • Many coenzymes are vitamins or contain vitamins as part of their structure • Functional unit of enzyme is known as holoenzyme – Holenzyme = Apoenzyme + Coenzyme • Apoenzyme : protein without any catalytic activity
  • 8. • If the enzyme is made of single polypeptide – monomeric enzyme. Ex: ribonuclease, trypsin • If the enzyme is made up of more than one polypeptide – oligomeric enzyme. Ex: lactate dehydrogenase, aspartate transcarbamoylase • Multienzyme complex: have multiple enzyme unit to carry out different reaction in sequence
  • 9. Factors effecting enzyme activity • The contact between enzyme and substrate is the most essential pre-requisite for enzyme activity. • The important factors that influence the enzyme reaction are – Concentration of Substrate – Concentration of Enzyme – Temperature – pH – Product concentration – Activators – Time – Light and radiation
  • 10. Concentration of Substrate: • The frequency with which molecules collide is directly proportionate to their concentrations Rate ∝ [A]n[B]m, Rate= k[A]n[B]m – where, nA + mB →P;k =rate constant • The sum of the molar ratios of the reactants defines the kinetic order of the reaction • In the example above, reaction is said to be of (n+m) order overall but n order with respect to A and m order with respect to B
  • 11. Michaelis-Menten Constant Km • Also known as Haldane’s Constant • Substrate concentration to produce half maximum velocityin an enzyme catalyst reaction • Km is constant and a chracterstic feature of a given enzyme – strength of Enzyme Substrate (ES) complex • Low Km value indicates a strong affinity between enzyme and substrate • Majority of Enzyme Km value – 10-5 to 10-2
  • 13. Concentration of Enzyme • Reaction velocity is directly proportional to concentration of enzyme • Serum enzyme for diagnosis of disease – Known volume of serum and substrate taken at optimum pH and temperature – Enzyme is assayed in laboratory
  • 14. Temperature • Velocity of an enzyme reaction increase with the increase in temperature up to a maximum and then declines • Increase in temperature causes increases the kinetic energy of molecules • A bell-shaped curve is usually observed • Temperature coefficient Q10 : increase in enzyme velocity when the temperature is increased by 100C • Optimum temperature for most of enzyme – 40 – 45 0C • Beyond 500C there is denaturation of enzyme
  • 15. pH • Most intracellular enzymes exhibit optimal activity at pH values between 6 - 8. • Balance between enzyme denaturation at high or low pH and effects on the charged state of the enzyme, the substrates, or both • Exception – pepsin (1-2), acid phosphatase (4- 5), alkaline phophatase (10-11)
  • 16. Activators • Certain metallica cations – Mn, Mg, Zn, Ca, Co, Cu, Na, K. • It acts in a various ways – Combining with substrate – Formation of E-S metal complex, direct participation in the reaction and bringing a conformational changes in enzyme • There are 2 categories of enzyme requiring metals for their activity • Metal activated enzyme:Not tightly held by the enzyme and can be exchanged easily. Ex: ATPAase (Mg and Ca) and Enolase • Metalloenzyme: Hold the metal tightly. Ex: alcohol dehydrogenase, carbonic anhydrase, alkaline phosphatase, carboxypeptidase
  • 17. Other Factor • Product concentration: Accumulation of reaction products generally decreases the enzyme velocity • Light and radiation: exposure to UV, beta- gamma and X-rays inactivates certain enzyme – Formation of peroxides, ex: UV rays inhibit salivary amylase activity
  • 18. Mechanism of Enzyme Action: Active Sites • The active site of an enzyme is the region that binds substrates, co-factors and prosthetic groups and contains residue that helps to hold the substrate. • Active sites generally occupy less than 5% of the total surface area of enzyme. • Active site has a specificshapedue to tertiary structure of protein. • A change in the shape of protein affects the shape of active site and function of the enzyme.
  • 19. Active Sites This model (above) is an enzyme called Ribonuclease S, that breaks up RNA molecules. It has three active sites(arrowed). Active site: The active site contains both binding and catalytic regions. The substrate is drawn to the enzyme’s surfaceand the substrate molecule(s) are positioned in a way to promote a reaction: either joining two molecules together or splitting up a larger one.Enzyme molecule: The complexity of the active site is what makes each enzyme so specific (i.e. precise in terms ofthe substrate it acts on). Substrate molecule: Substrate molecules are the chemicals that an enzyme acts on. They are drawn into the cleft of the enzyme.
  • 20. Mechanism of enzyme action • The catalytic efficiency of enzymes is explained by two perspectives: Thermodynamic changes Processes at the active site
  • 21. Thermodynamic changes • All chemical reactions have energy barriers between reactants and products. • The difference in transitional state and substrate is called activational barrier.
  • 22. Lock and Key Model Substrate Enzyme Products Symbolic representation of the lock and key model of enzyme action. 1. A substrate is drawn into the active sites of theenzyme. 2. The substrate shape must be compatible with the enzymes active site in order to fit and be reacted upon. 3. The enzyme modifies the substrate. In this instance the substrateis broken down, releasing two products.
  • 23. I n d u c e d f i t m o d e l • More recent studies have revealed that the process is much more likely to involve an induced fit model(proposed by DANIAL KOSH LAND in 1958). • According to this exposure of an enzyme to substrate cause a change in enzyme, which causes the active site to change it’s shape to allow enzyme and substrate to bind.
  • 24. In h i b i t i o n o The prevention of an enzyme processas a result of interaction of inhibitors with the enzyme.  INHIBITORS: Any substance that can diminish the velocity of an enzyme catalyzed reaction is called an inhibitor.
  • 25. A. REVERSIBLE INHIBITION o It is an inhibition of enzyme activity in which the inhibiting molecular entity can associate and dissociate from the protein‘s bindingsite. TYPES OF REVERSIBLE INHIBITION o There are four types:  Competitive inhibition.  Uncompetitive inhibition.  Mixed inhibition.  Non-competitive inhibition.
  • 26. C o m p e t i t i v e i n h i b i t i o n • In this type of inhibition, the inhibitors compete with the substrate for the active site. Formation of E.S complex is reduced while a new E.I complex is formed. Example: • Statin drugs such as lipitor compete with HMG- CoA(substrate) and inhibit the active site of HMG CoA-REDUCTASE (that bring about the catalysis of cholesterol synthesis).
  • 27. U n c o m p e t i t i v e I n h i b i t i o n • In this type of inhibition, inhibitor does not compete with the substrate for the active site of enzyme instead it binds to another site known as allosteric site. Example: • Drugs to treat cases of poisoning by methanol or ethylene glycol act as uncompetitive inhibitors. • Tetramethylene sulfoxide and 3- butylthiolene 1-oxide are uncompetitive inhibitors of liver alcohaldehydrogenase.
  • 28. MI X E D INHIBITION o In this type of inhibition both E.I and E.S.I complexes are formed. o Both complexes are catalytically inactive. N o n c o m p e t i t i v e i n h i b i t i o n o It is a special case of inhibition. o In this inhibitor has the same affinity for either enzyme E or the E.S complex.
  • 29. B. Irreversible i n h i b i t i o n • This type of inhibition involves the covalent attachment of the inhibitor to the enzyme. • The catalytic activity of enzyme is completely lost. • It can only be restored only by synthesizing molecules. www.facebook.com/notesdent al
  • 30. E x a m p l e s o f i r r e v e r s i b l e i n h i b i t i o n • Aspirin which targets and covalently modifies a key enzyme involved in inflammation is an irreversible inhibitor. • SUICIDE INHIBITION : It is an unusual type of irreversible inhibition where the enzyme converts the inhibitor into a reactive form in its active site.
  • 31. Diagnostic Importance of Enzyme • Estimation of enzyme activities in biological fluid is of great clinical importance. • The enzyme can be divided in 2 groups: – Plasma Specific or plasma functional enzyme – Non-plasma specific or plasma non-functional enzyme
  • 32. Plasma Specific • Present in the plasma normally and have specific fucntion • Their value is higher in plasma than tissue • They are mainly synthesized in liver and enter the circulation • Ex: Lipoprotein lipase, plasmin, thrombin, choline esterase, ceruloplasmin • Impairment of liver function or genetic disorder – leads to enzyme deficiency • Wilson disease – deficiency of ceruloplasmin
  • 33. Non-plasma specific • These enzymes are present in the low level in plasma compared to the tissue • Estimation of activities of these enzymes serves for the diagnosis and prognosis of several disease - markers of disease • The raised enzyme level may indicate – Cellular damage – Increased rate of cell turnover – Proliferation of cells – Increased synthesis of enzymes
  • 34. Important Diagnostic Enzymes • Amylase – Acute pancreatitis • Serum glutamate pyruvate transferase (SGPT) – liver disease (hepatitis) • Serum glutamate oxaloacetate transaminase (SGOT) – Heart attacks (myocardial infarction) • Alkaline phosphatase – Rickets, obstructive jaundice • Acid phophatase – cancer of prostate gland • Lactate dehydrogenase (LDH) – heart attacks, liver disease • Creatinine phosphokinase (CPK) – myocardial infarction • Aldolase – Muscular dystrophy
  • 35. Amylase • Activity increased in acute pancreatitis • Normal level – 0.2-1.5 IU/l • Peak value in 8-12 hrs – onset of disease and returns to normal in 3-4 days • Urine analysis • Serum analysis – chronic pancreatitis, acute parotitis (mumps) and obstruction of pancreatic duct
  • 36. Serum glutamate pyruvate transferase (SGPT) • Also known as Alanine transaminase (ALT) • Normal level – 3-4.0 IU/l • Acute hepatitis of viralor toxic origin • Jaundice and cirrohosis of liver
  • 37. Serum glutamate oxaloacetate transaminase (SGOT) • Also known as Aspartate transaminase • Normal 4-4.5 IU/l • Increase in myocardial infarction and also in liver diseases • SGPT is more specific for liver disease and SGOT for MI – SGPT more cytosomal enzyme while SGOT is cytosol and mitochondria
  • 38. Alkaline phosphatase • Elevated in bone and liver disease • Normal : 25-90 IU/l • Diagnosis for – Rickets, – Hyperparathyroidism, – Carcinoma of bone – Obstructive jaundice – Paget’s Disease
  • 39. Acid phophatase • Normal : 0.5 -4 KA units/dl • Increased in cancer of prostate gland and Paget’s Disease • Good tumor marker Creatinine phosphokinase (CPK) • Normal : 10-50 IU/l • Diagnosis of – MI - Very early detection – Muscular dystrophy – Hypothyroidism – Alcoholism
  • 40. Lactate dehydrogenase (LDH) • At least five different isozymes • Assess the timing and extent of heart damage due to myocardial infarction MI (heart attack) – 12 hrs of MI: blood level of total LDH increases, and there is more LDH2 than LDH1 – 24 hrs of MI: more LDH1 than LDH2 Type Composition Location LDH1 HHHH Heart and erythrocyte LDH2 HHHM Heart and erythrocyte LDH3 HHMM Brain and kidney LDH4 HMMM Skeletal muscle and liver LDH5 MMMM Skeletal muscle and liver
  • 41. Aldolase • Normal ; 2+6 IU/l • Diagnosis of – Muscular dystrophy – Liver disease – Myocardial infarction – Myasthenia gravis – Leukemia